nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—DRD2—nicotine dependence	0.865	1	CbGaD
Mesoridazine—DRD3—Dopamine receptors—DRD2—nicotine dependence	0.00616	0.0536	CbGpPWpGaD
Mesoridazine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00571	0.0497	CbGpPWpGaD
Mesoridazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00437	0.038	CbGpPWpGaD
Mesoridazine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00368	0.032	CbGpPWpGaD
Mesoridazine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00309	0.0269	CbGpPWpGaD
Mesoridazine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.003	0.0261	CbGpPWpGaD
Mesoridazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00282	0.0245	CbGpPWpGaD
Mesoridazine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00264	0.023	CbGpPWpGaD
Mesoridazine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00241	0.021	CbGpPWpGaD
Mesoridazine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.0024	0.0209	CbGpPWpGaD
Mesoridazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.0023	0.02	CbGpPWpGaD
Mesoridazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00202	0.0176	CbGpPWpGaD
Mesoridazine—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD2—nicotine dependence	0.00195	0.017	CbGpPWpGaD
Mesoridazine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00192	0.0167	CbGpPWpGaD
Mesoridazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00184	0.016	CbGpPWpGaD
Mesoridazine—HTR6—Monoamine GPCRs—DRD2—nicotine dependence	0.0016	0.0139	CbGpPWpGaD
Mesoridazine—DRD3—Monoamine GPCRs—DRD2—nicotine dependence	0.00136	0.0118	CbGpPWpGaD
Mesoridazine—HTR6—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00135	0.0117	CbGpPWpGaD
Mesoridazine—CHRM2—cardiovascular system—nicotine dependence	0.00122	0.0962	CbGeAlD
Mesoridazine—HTR1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00119	0.0103	CbGpPWpGaD
Mesoridazine—HTR2C—Monoamine GPCRs—DRD2—nicotine dependence	0.00118	0.0103	CbGpPWpGaD
Mesoridazine—DRD3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00114	0.00995	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00111	0.00962	CbGpPWpGaD
Mesoridazine—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.00106	0.0092	CbGpPWpGaD
Mesoridazine—DRD3—brain—nicotine dependence	0.00104	0.0818	CbGeAlD
Mesoridazine—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00102	0.00891	CbGpPWpGaD
Mesoridazine—HRH1—Monoamine GPCRs—DRD2—nicotine dependence	0.00102	0.0089	CbGpPWpGaD
Mesoridazine—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00101	0.00875	CbGpPWpGaD
Mesoridazine—HTR6—brain—nicotine dependence	0.001	0.0787	CbGeAlD
Mesoridazine—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.001	0.00872	CbGpPWpGaD
Mesoridazine—HTR1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000997	0.00867	CbGpPWpGaD
Mesoridazine—HTR1A—cardiovascular system—nicotine dependence	0.000993	0.078	CbGeAlD
Mesoridazine—HTR2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000991	0.00863	CbGpPWpGaD
Mesoridazine—Acetophenazine—DRD2—nicotine dependence	0.000941	0.128	CrCbGaD
Mesoridazine—DRD3—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000928	0.00808	CbGpPWpGaD
Mesoridazine—HTR2C—midbrain—nicotine dependence	0.000922	0.0724	CbGeAlD
Mesoridazine—KCNH2—cardiovascular system—nicotine dependence	0.000884	0.0695	CbGeAlD
Mesoridazine—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000861	0.00749	CbGpPWpGaD
Mesoridazine—HRH1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000859	0.00748	CbGpPWpGaD
Mesoridazine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000845	0.00736	CbGpPWpGaD
Mesoridazine—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000809	0.00704	CbGpPWpGaD
Mesoridazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000796	0.00693	CbGpPWpGaD
Mesoridazine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000785	0.00684	CbGpPWpGaD
Mesoridazine—HTR1A—midbrain—nicotine dependence	0.000776	0.0609	CbGeAlD
Mesoridazine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.000775	0.00675	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000738	0.00642	CbGpPWpGaD
Mesoridazine—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.000724	0.0063	CbGpPWpGaD
Mesoridazine—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00071	0.00618	CbGpPWpGaD
Mesoridazine—DRD2—midbrain—nicotine dependence	0.000701	0.055	CbGeAlD
Mesoridazine—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.000694	0.00604	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000694	0.00604	CbGpPWpGaD
Mesoridazine—KCNH2—midbrain—nicotine dependence	0.000691	0.0542	CbGeAlD
Mesoridazine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000686	0.00597	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00067	0.00583	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—TAS2R16—nicotine dependence	0.000662	0.00576	CbGpPWpGaD
Mesoridazine—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.000646	0.00562	CbGpPWpGaD
Mesoridazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000645	0.00561	CbGpPWpGaD
Mesoridazine—CHRM2—brain—nicotine dependence	0.000601	0.0472	CbGeAlD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000599	0.00522	CbGpPWpGaD
Mesoridazine—HTR2A—cardiovascular system—nicotine dependence	0.000592	0.0465	CbGeAlD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000588	0.00512	CbGpPWpGaD
Mesoridazine—HTR2C—brain—nicotine dependence	0.000579	0.0455	CbGeAlD
Mesoridazine—Triflupromazine—DRD2—nicotine dependence	0.000577	0.0783	CrCbGaD
Mesoridazine—DRD3—GPCR ligand binding—TAS2R16—nicotine dependence	0.000562	0.00489	CbGpPWpGaD
Mesoridazine—Acepromazine—DRD2—nicotine dependence	0.000534	0.0725	CrCbGaD
Mesoridazine—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.000526	0.00458	CbGpPWpGaD
Mesoridazine—Thioproperazine—DRD2—nicotine dependence	0.000522	0.0708	CrCbGaD
Mesoridazine—Pipotiazine—DRD2—nicotine dependence	0.000514	0.0697	CrCbGaD
Mesoridazine—Thiothixene—DRD2—nicotine dependence	0.000514	0.0697	CrCbGaD
Mesoridazine—Prochlorperazine—DRD2—nicotine dependence	0.000491	0.0666	CrCbGaD
Mesoridazine—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00049	0.00426	CbGpPWpGaD
Mesoridazine—HTR1A—brain—nicotine dependence	0.000487	0.0383	CbGeAlD
Mesoridazine—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.000487	0.00424	CbGpPWpGaD
Mesoridazine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.000482	0.0042	CbGpPWpGaD
Mesoridazine—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.000463	0.00403	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000463	0.00403	CbGpPWpGaD
Mesoridazine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000463	0.00403	CbGpPWpGaD
Mesoridazine—HTR2A—midbrain—nicotine dependence	0.000462	0.0363	CbGeAlD
Mesoridazine—Fluphenazine—DRD2—nicotine dependence	0.000444	0.0602	CrCbGaD
Mesoridazine—DRD2—brain—nicotine dependence	0.00044	0.0346	CbGeAlD
Mesoridazine—KCNH2—brain—nicotine dependence	0.000434	0.0341	CbGeAlD
Mesoridazine—DRD3—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000434	0.00377	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00043	0.00374	CbGpPWpGaD
Mesoridazine—HTR6—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000427	0.00372	CbGpPWpGaD
Mesoridazine—Propiomazine—DRD2—nicotine dependence	0.000427	0.0579	CrCbGaD
Mesoridazine—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000423	0.00368	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000422	0.00367	CbGpPWpGaD
Mesoridazine—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.000421	0.00366	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00042	0.00366	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000415	0.00362	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0004	0.00348	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000393	0.00342	CbGpPWpGaD
Mesoridazine—DRD3—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000391	0.00341	CbGpPWpGaD
Mesoridazine—Thioridazine—DRD2—nicotine dependence	0.000383	0.0519	CrCbGaD
Mesoridazine—HTR6—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000374	0.00325	CbGpPWpGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000366	0.00319	CbGpPWpGaD
Mesoridazine—Methotrimeprazine—DRD2—nicotine dependence	0.000365	0.0495	CrCbGaD
Mesoridazine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000364	0.00316	CbGpPWpGaD
Mesoridazine—DRD3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000363	0.00316	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000363	0.00316	CbGpPWpGaD
Mesoridazine—Promethazine—DRD2—nicotine dependence	0.00036	0.0488	CrCbGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000356	0.0031	CbGpPWpGaD
Mesoridazine—Trifluoperazine—DRD2—nicotine dependence	0.000355	0.0481	CrCbGaD
Mesoridazine—Perphenazine—DRD2—nicotine dependence	0.000351	0.0476	CrCbGaD
Mesoridazine—HRH1—brain—nicotine dependence	0.000348	0.0273	CbGeAlD
Mesoridazine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000343	0.00298	CbGpPWpGaD
Mesoridazine—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000341	0.00297	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—TAS2R16—nicotine dependence	0.00034	0.00296	CbGpPWpGaD
Mesoridazine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000338	0.00294	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000332	0.00289	CbGpPWpGaD
Mesoridazine—DRD3—Circadian rythm related genes—DRD2—nicotine dependence	0.000321	0.00279	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000318	0.00276	CbGpPWpGaD
Mesoridazine—Promazine—DRD2—nicotine dependence	0.000316	0.0429	CrCbGaD
Mesoridazine—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000316	0.00275	CbGpPWpGaD
Mesoridazine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000315	0.00274	CbGpPWpGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000311	0.00271	CbGpPWpGaD
Mesoridazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000309	0.00269	CbGpPWpGaD
Mesoridazine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000299	0.00261	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—FGD1—nicotine dependence	0.000293	0.00255	CbGpPWpGaD
Mesoridazine—HTR2A—brain—nicotine dependence	0.000291	0.0228	CbGeAlD
Mesoridazine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000289	0.00252	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000288	0.00251	CbGpPWpGaD
Mesoridazine—DRD3—G alpha (i) signalling events—DRD2—nicotine dependence	0.000283	0.00246	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—OPRM1—nicotine dependence	0.000279	0.00243	CbGpPWpGaD
Mesoridazine—Chlorpromazine—DRD2—nicotine dependence	0.000279	0.0378	CrCbGaD
Mesoridazine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000278	0.00242	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000277	0.00241	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000275	0.0024	CbGpPWpGaD
Mesoridazine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000273	0.00238	CbGpPWpGaD
Mesoridazine—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000273	0.00237	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000271	0.00236	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00027	0.00235	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000268	0.00234	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—FGD1—nicotine dependence	0.000266	0.00232	CbGpPWpGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000265	0.0023	CbGpPWpGaD
Mesoridazine—CYP2D6—brain—nicotine dependence	0.000265	0.0208	CbGeAlD
Mesoridazine—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000263	0.00228	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000251	0.00219	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00025	0.00218	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—FGD1—nicotine dependence	0.000249	0.00217	CbGpPWpGaD
Mesoridazine—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000247	0.00215	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000243	0.00212	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000239	0.00208	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000239	0.00208	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000238	0.00207	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—OPRM1—nicotine dependence	0.000237	0.00206	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000235	0.00204	CbGpPWpGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000234	0.00204	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000234	0.00203	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00023	0.002	CbGpPWpGaD
Mesoridazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000229	0.00199	CbGpPWpGaD
Mesoridazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000228	0.00198	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—FGD1—nicotine dependence	0.000226	0.00197	CbGpPWpGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000225	0.00196	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000221	0.00192	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000217	0.00189	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000217	0.00189	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000217	0.00189	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000216	0.00188	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000213	0.00186	CbGpPWpGaD
Mesoridazine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000209	0.00182	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000206	0.0018	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000205	0.00179	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—DRD2—nicotine dependence	0.000202	0.00176	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	0.000201	0.00175	CbGpPWpGaD
Mesoridazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000198	0.00172	CbGpPWpGaD
Mesoridazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000197	0.00172	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000197	0.00172	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000196	0.00171	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000196	0.00171	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000195	0.0017	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000194	0.00169	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000191	0.00166	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000188	0.00163	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000187	0.00163	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000184	0.0016	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000181	0.00158	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000178	0.00155	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000178	0.00155	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000175	0.00152	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000173	0.00151	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—DRD2—nicotine dependence	0.000171	0.00149	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.00017	0.00148	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	0.00017	0.00148	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.00017	0.00148	CbGpPWpGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000169	0.00147	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000169	0.00147	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000167	0.00146	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000166	0.00145	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	0.000158	0.00137	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—FGD1—nicotine dependence	0.000157	0.00137	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000149	0.0013	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000148	0.00129	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000148	0.00129	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000148	0.00129	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	0.000143	0.00125	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	0.000139	0.00121	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000134	0.00117	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—FGD1—nicotine dependence	0.000134	0.00116	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.00013	0.00113	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000129	0.00112	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.000129	0.00112	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000128	0.00112	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.000128	0.00111	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000127	0.0011	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000126	0.0011	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	0.000122	0.00106	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	0.000118	0.00103	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000117	0.00102	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	0.000117	0.00101	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000116	0.00101	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.000116	0.00101	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	0.000114	0.000992	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000106	0.000922	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000105	0.000917	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—DRD2—nicotine dependence	0.000103	0.000901	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000103	0.000896	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000102	0.000892	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000102	0.000891	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FGD1—nicotine dependence	0.000102	0.00089	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000101	0.000877	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	0.000101	0.000876	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000101	0.000875	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FGD1—nicotine dependence	0.0001	0.000874	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	9.9e-05	0.000861	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	9.88e-05	0.00086	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—WASF2—nicotine dependence	9.8e-05	0.000853	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	9.68e-05	0.000842	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—WASF1—nicotine dependence	9.39e-05	0.000817	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	9.3e-05	0.00081	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	9.15e-05	0.000797	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	9.13e-05	0.000795	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	9.04e-05	0.000786	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	8.99e-05	0.000782	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	8.89e-05	0.000774	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	8.87e-05	0.000772	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—DRD2—nicotine dependence	8.79e-05	0.000765	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	8.73e-05	0.00076	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—OPRM1—nicotine dependence	8.46e-05	0.000736	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	8.44e-05	0.000734	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	8.39e-05	0.00073	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—WASF2—nicotine dependence	8.32e-05	0.000724	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—WASF1—nicotine dependence	7.98e-05	0.000694	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	7.66e-05	0.000667	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	7.62e-05	0.000663	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	7.29e-05	0.000634	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	7.27e-05	0.000633	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	7.25e-05	0.000631	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	7.21e-05	0.000628	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—OPRM1—nicotine dependence	7.18e-05	0.000625	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	7.15e-05	0.000623	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	6.95e-05	0.000605	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	6.92e-05	0.000602	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	6.62e-05	0.000576	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	6.6e-05	0.000575	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	6.5e-05	0.000566	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—WASF2—nicotine dependence	6.37e-05	0.000554	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	6.26e-05	0.000545	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	6.26e-05	0.000545	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—WASF2—nicotine dependence	6.25e-05	0.000544	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	6.23e-05	0.000542	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	6.15e-05	0.000535	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—DRD2—nicotine dependence	6.11e-05	0.000532	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—WASF1—nicotine dependence	6.1e-05	0.000531	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	6.01e-05	0.000523	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—WASF1—nicotine dependence	5.99e-05	0.000522	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	5.9e-05	0.000513	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	5.86e-05	0.00051	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	5.5e-05	0.000478	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	5.41e-05	0.000471	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	5.4e-05	0.00047	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	5.31e-05	0.000462	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—DRD2—nicotine dependence	5.19e-05	0.000452	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	4.53e-05	0.000394	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	4.5e-05	0.000392	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	3.91e-05	0.00034	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—DRD2—nicotine dependence	3.9e-05	0.00034	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	3.84e-05	0.000334	CbGpPWpGaD
